We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medicx Fund | LSE:MXF | London | Ordinary Share | GG00B1DVQL92 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 96.40 | 95.80 | 96.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/10/2014 12:42 | And still they continue to expand | badtime | |
14/7/2014 11:39 | Good yield from predictable portfolio - Investor relations contacts - | speedsgh | |
14/7/2014 11:32 | betman - hope this helps... "MedicX Fund is a self-managed closed-ended investment company, incorporated in 2006 and domiciled in Guernsey. MedicX Fund receives investment advice from MedicX Adviser, a member of the MedicX Group, which is a specialist investor in, developer of and manager of healthcare properties. The Fund's investment objective is to achieve rising rental income and capital growth from the ownership of a portfolio of mainly modern purpose built primary healthcare properties." | speedsgh | |
11/7/2014 17:26 | Apologies if this is a stupid question. Is this an Investment trust ? Or a REIT ? Or just a property fund. It seems to be a closed ended fund, but if cannot find their management charges. The yield looks too good to be true, but steadily growing over multiple years | betman | |
04/6/2014 13:05 | I don't think this adds too much to the fairly obvious, but worth a look anyway | 1ch1ban | |
31/5/2014 08:55 | I also looked at the Interims and was concerned at the way equity fund raisings at below asset value reduce the asset value per share and the dividend cover. WE are relying very much on good increases in asset value to offset this. However the asset value growth will be constrained by the long leases at low review increases It seems to me that it would be in the best interests of shareholders to halt rapid further expansion and dilutive equity fund raising and let the situation unwind. The only beneficiary from this chain of acquisitions and fund raising is the Managers with their capital value based fees.A big incentive for them to expand. This also applies to PHP who are on the same merry go round. Interesting that Assura , which is self managed has it's divi fully covered GAN | ganthorpe | |
30/5/2014 07:33 | My biggest holding by far. Why? Well managed & comfortable level of debt (as shown in today's Half Yearly figures), growing demand for new surgeries in new communities is setting sensible and sustainable rental levels, predictable rent review increases across the portfolio and chunky yield (I bought for income in the 60p era and have topped up on the two rights issues only).I recognise that the dividend is not covered, and that is the only negative. Reviews will catch up with that in time.Steady as she goes. | 1ch1ban | |
21/5/2014 19:49 | I also hold AGR from low 30's and a bit higher | badtime | |
21/5/2014 10:54 | I hold a few too. OK till interest rates go up -then maybe too much debt for this yield? | 4spiel | |
20/5/2014 13:45 | yes, been holding for some considerable time. | speedsgh | |
20/5/2014 13:20 | I hold a few...anyone else? | badtime | |
14/5/2014 09:57 | XDIV today another 1.45 | badtime | |
18/2/2014 14:37 | Just received the following email in my inbox... WANTED. Land for care and senior living development. MedicX, a leading investor and developer in healthcare property, is looking for land opportunities throughout the UK for the development of new private care homes with the following key features: ~ 2 to 5 acres ~ Accessible and close to large towns ~ £500,000 - £2 million Unconditional purchases considered. Fees available for successful off-market introductions. Tom Bagnall 01483 869 510 / 07889 010 295 tom.bagnall@medicx.c Or submit your site details at: www.medicx.com/land- | speedsgh | |
17/10/2013 10:46 | As a Wednesdayite, it comes with the territory.. :-) | wirralowl | |
16/10/2013 21:16 | lol....i was toying with the idea of popping back in now theyve pulled back a tad | badtime | |
16/10/2013 21:00 | - and negative thinking :) | asmodeus | |
16/10/2013 19:50 | I'm still here and taken up my entitlement. Probably should've sold on the spike earlier in the year and bought back, but you know what they say about hindsight... | wirralowl | |
16/10/2013 18:51 | all gone a tad quiet here | badtime | |
02/7/2013 03:43 | now at 75p, quite a big drop today, xd was 17 may any ideas? maybe the market is realigning share price with NAV | cnx | |
06/6/2013 16:16 | was wondering the same, badtime...lots of buys going through, maybe its been tipped somewhere? | wirralowl | |
06/6/2013 16:13 | Any clues as to why the increase | badtime | |
29/5/2013 07:24 | Well it isn't happening, but yesterday's statement from Assura really shows the flaws in MedicX model. Dividend is being paid almost 50% from borrowings and there is a significant manager's fee (unlike Assura). Today's results also shows that the NAV is well below the current share price. | goliard | |
21/5/2013 09:42 | Assura pays a much lower level of divi than Medic. As A medic holder it worries me that Assura holders will get a much increased divi after the merger and can Medic afford it and reduce the dividend cover which is already below 100%. Or will we see a reduced divi level? A bridge too far? I would prefer NOT to see an Assura merger. GAN | ganthorpe | |
20/5/2013 08:44 | Odd that the recent and unexpected rise to 87p happened just before the Assura offer. If I was being unkind I would ask if it was a concerted attempt to raise the MedicX price and make the offer look more attractive. At the previous MedicX price around 77p the offer doesn't seem so good. Hoping PHP might come in and upset the party! | goliard |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions